Biden tests positive for COVID, has ‘very mild symptoms,’ White House says
admin President Joe Biden tested positive for COVID-19 on Thursday morning, White House press secretary Karine…
Read MorePharmaceuticals
Roche backs 2022 outlook as profit climbs, boosted by diagnostics sales
Roche Holding AG said Thursday that profit for the first half of the year increased…
Read MoreAbbott is now aiming to recover the baby-formula market share that it lost
Abbott Laboratories ABT, -1.55% is focused on recovering its position in the baby-formula market in…
Read MoreBernstein still sees more pain ahead for stocks, until capitulation triggers bonafide rally next year
How bad is the mood out there right now? Try max bearish. So said Bank…
Read MoreNovartis sales and profit drop, but backs 2022 guidance
Corrections & Amplifications This headline was corrected at 0516 GMT becuase the core oper income…
Read MoreDow Jones Newswires: Novartis sales and profit drop, but backs 2022 guidance
The Swiss pharmaceutical company on Tuesday posted net profit of $1.69 billion, down from $2.89…
Read MoreCelcuity stock soars after hours on breakthrough therapy designation for cancer drug
Shares of Celcuity Inc. CELC were up 17% at $10.80 after hours as the U.S.…
Read MoreU.S. COVID cases tick higher as BA.5 takes hold, and U.K. to offer second booster to those aged 50 and older
U.S. COVID cases are rising again after being steady for several months, as the BA.5…
Read MoreU.S. COVID cases tick higher as BA.5 takes hold, and U.K. to offer second booster to those aged 50 and older
U.S. COVID cases are rising again after being steady for several months, as the BA.5…
Read MoreMerck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say
Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized…
Read More